Healthtech Startup Growth

You don’t scale a HealthTech product. You localise it hundreds of times. I’ve lost count of how many times I’ve heard: “Once we get this working in [insert Trust name], we’ll scale across the region.” Here’s what actually happens: You get it working in one Trust. You go next door, and the whole thing unravels. Different data. Different workflows. Different stakeholders Different funding quirks Different operating policies Same product. Completely different install. What looks like ‘scale’ on a slide deck... often is duct tape in real life. Because healthcare isn’t a single market. It’s a hundreds micro-markets stitched together. And each of those micro-markets will make your product: Integrate differently Justify ROI differently Be evaluated by a different stakeholders Be owned by someone with a different job title Be used in a slightly different way to meet local workflows. If you’re good, it still works. If you’re great, you’ve made it feel like it works the same. But under the hood? It can often become a mess of adaptations: Custom pathways for another’s triage model Manual workarounds no one dares document Hard-coded rules for one Trust’s discharge process A version of your product that no longer matches your pitch deck IMO success isn’t scale. It’s survivability. It's adaptability. Because you don’t really deploy once and scale. You localise again, and again, and again… until someone else calls it scale. I once had a a 'standard' product that could be customised in over 500 ways to meet the nuances of each deployment. However these adaptations are your competitive advantage. Because the only “scalable” HealthTech products are the ones flexible enough to be localised hundreds of times... without breaking.

I've watched 3 "revolutionary" healthcare technologies fail spectacularly. Each time, the technology was perfect. The implementation was disastrous. Google Health (shut down twice). Microsoft HealthVault (lasted 12 years, then folded). IBM Watson for Oncology (massively overpromised). Billions invested. Solid technology. Total failure. Not because the vision was wrong, but because healthcare adoption follows different rules than consumer tech. Here's what I learned building healthcare tech for 15 years: 1/ Healthcare moves at the speed of trust, not innovation ↳ Lives are at stake, so skepticism is protective ↳ Regulatory approval takes years usually for good reason ↳ Doctors need extensive validation before adoption ↳ Patients want proven solutions, not beta testing 2/ Integration trumps innovation every time ↳ The best tool that no one uses is worthless ↳ Workflow integration matters more than features ↳ EMR compatibility determines adoption rates ↳ Training time is always underestimated 3/ The "cool factor" doesn't predict success ↳ Flashy demos rarely translate to daily use ↳ Simple solutions often outperform complex ones ↳ User interface design beats artificial intelligence ↳ Reliability matters more than cutting-edge features 4/ Reimbursement determines everything ↳ No CPT code = no sustainable business model ↳ Insurance coverage drives provider adoption ↳ Value-based care is changing this slowly ↳ Free trials don't create lasting change 5/ Clinical champions make or break technology ↳ One enthusiastic doctor can drive adoption ↳ Early adopters must see immediate benefits ↳ Word-of-mouth beats marketing every time ↳ Resistance from key stakeholders kills innovations The pattern I've seen: companies build technology for the healthcare system they wish existed, not the one that actually exists. They optimize for TechCrunch headlines instead of clinic workflows. They design for Silicon Valley investors instead of 65-year-old physicians. A successful healthcare technology I've implemented? A simple visit summarization app that saved me time and let me focus on the patient. No fancy interface, very lightweight, integrated into my clinical workflow, effortless to use. Just solved an problem that users had. Healthcare doesn't need more revolutionary technology. It needs evolutionary technology that works within existing systems. ⁉️ What's the simplest technology that's made the biggest difference in your healthcare experience? Sometimes basic beats brilliant. ♻️ Repost if you believe implementation beats innovation in healthcare 👉 Follow me (Reza Hosseini Ghomi, MD, MSE) for realistic perspectives on healthcare technology

Most MedTech startups don’t fail. They just never really scale. Approved. Launched. Selling… a bit. And then they plateau. For years. After working with multiple MedTech startups, I’ve seen a common pattern: The issue isn’t bad technology. It’s underfunded ambition. In MedTech, fundraising isn’t a side task for the CEO. It’s the strategic lever that determines whether the company becomes relevant or remains “interesting.” Here’s where lack of capital quietly kills momentum: 1. Evidence beyond approval The FDA or CE study gets you on the market. It does not get you adoption. Without funding, there’s no: - Sequenced evidence strategy aligned to commercial goals - Comparative data - EU MDR follow-up studies - Payer-relevant endpoints Thin evidence = slow traction. 2. Commercial leadership early enough Hiring a commercial lead 3–6 months before launch is not strategy. It’s damage control. To win, that role should be in place 12+ months before launch with real budget for: - Market development - Positioning - Organizational readiness An early hire without resources is just expensive hope. 3. Marketing that actually educates the market If you don’t fund marketing: - The market doesn’t understand your value - You navigate without real market insight - Sales cycles stretch - Pricing erodes Sales teams cannot build a category alone. 4. Market Access as a capability Global Value Dossiers. Budget Impact Models. Local reimbursement work. Underfund this, and growth stalls 12–24 months post-launch, just when investors expect acceleration. 5. Geographic optionality Focusing on the U.S. is logical. But starving Europe or other regions to “save cash” often destroys long-term value. Preserving options early is affordable. Rebuilding them later is not. The uncomfortable truth: Many MedTech companies never break through because they were never funded to. They linger in permanent scale-up mode. So here’s the real question: Did the CEO raise enough capital to build relevance? Or did investors underestimate what it truly takes to win in MedTech? Because in this industry, capital isn’t about survival. It’s about impact. If you want your company to matter, fund it like it should. ----------------------------------------------------------- I help MedTech companies build real momentum, especially in Europe. Let’s talk. 🔔 Ring my bell to get more posts like this. 🔁 Share if you want to make sure MedTech companies get appropriate funding. 👤 Follow me (Laurent Laffineur) for more insights.

Every week, I get a 10 new startup pitches that says “We’ll deliver healthcare in 10 minutes.” Quick commerce is now rushing into healthcare. So I thought to do a breakdown on what’s hype and what might actually work in India. What could work? 1)30–60 min medicine delivery can work for chronic refills or acute needs. In metros with dense demand, it's useful. But 10-min isn’t necessary. Even same-day is fine for 90% of use cases. And honestly, your local chemist is already doing that. 2) Rapid diagnostics for home blood collection isn’t about speed but it’s about hygiene and reliability. A 2-hour sample pickup and next-morning results is a solid win. What we need is better logistics and trained phlebotomists, not faster scooters. 3)On-demand nursing or paramedic visits but for use cases like wound care, IV, injections. Could work with proper scheduling. Think “Ola for nurses,” not “Blinkit for bandages.” Needs backend infra for verification, training, EMR integration. What won’t work (At least not now) 1) Ambulance in 10 mins sounds great until you hit Delhi or Bangalore traffic. Speed is useless without triage and location accuracy. What we really need is better coordination between hospitals and ambulance providers, not just faster wheels. 2) On-demand doctors in 10 mins is a bad idea. You don’t need any doctor fast but you need the right one. Discovery & matching are bigger problems than speed. Most video consults struggle with quality, not timing. Clinical care isn’t fast food. Trust takes time. 3) The 10-min everything app for healthcare is lazy ambition dressed up with VC money. Healthcare isn’t a SKU game but it’s complex, regulated, and hard to standardize like groceries. Great for funding buzz, terrible for trust and real outcomes. Few thoughts if you really are passionate to build in healthcare. Trust > velocity. Speed isn’t everything. Infra & people ops > APIs. Reliability > 10-min hacks. Health is longitudinal & not transactional. Good luck if you're building something in Healthcare in India.

Nearly 70% of healthtech innovations never reach the market. Launching a product in healthcare is 10x more complicated than regular tech products, so most first-time founders get lost along the way. After building and scaling over 100 healthtech products in the last 2 decades, here's the blueprint I use: ⏵ 1. Start with user needs Don't just survey doctors - observe them in action. Real insights come from watching how they interact with existing solutions. ⏵ 2. Prioritize regulatory compliance Begin documentation on day 1. The FDA looks at your entire development process, not just the final product. ⏵ 3. Clinical validation Get a medical advisory board early. Their expertise will shape your product and lend credibility with stakeholders. ⏵ 4. Establish data security One breach can kill your startup. Have redundant security measures, not just the minimum requirements. ⏵ 5. Design for scalability Your MVP should handle 100x your initial user base. Healthcare products can't afford downtime to rebuild. ⏵ 6. Focus on integration If you can't plug into existing hospital systems in under a week, most clients won't consider you. Period. ⏵ 7. Protect intellectual property File provisional patents before your first pitch. Healthcare giants have armies of lawyers watching startups. ⏵ 8. Plan for funding Budget 3x more time and money than you expect. The average healthtech product takes 18-24 months just to launch. Every step counts, and each decision plays a role in your success. Which step do you find most challenging? #healthtech #startups #innovation

The Hard Truth: 𝟴𝟬% 𝗼𝗳 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝘀𝘁𝗮𝗿𝘁𝘂𝗽𝘀 𝗳𝗮𝗶𝗹 𝘄𝗶𝘁𝗵𝗶𝗻 𝟱 𝘆𝗲𝗮𝗿𝘀 even with 7-𝗳𝗶𝗴𝘂𝗿𝗲 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗿𝗼𝘂𝗻𝗱𝘀 After working with 𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗶𝗰𝗲 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 over the past decade and supporting many 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝗺𝗮𝗿𝗸𝗲𝘁 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀. I’ve seen clear patterns that separate the winners from the ones that quietly disappear Here are 𝟳 𝗰𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗳𝗮𝗰𝘁𝗼𝗿𝘀 that consistently predict MedTech success: 1. 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝗧𝗶𝗺𝗲𝗹𝗶𝗻𝗲 𝗠𝗶𝘀𝗮𝗹𝗶𝗴𝗻𝗺𝗲𝗻𝘁 • Most startups underestimate FDA timelines by 𝟳𝟬%+ • They plan for 8–12 months when 𝟭𝟴–𝟮𝟰 𝗺𝗼𝗻𝘁𝗵𝘀 is more realistic • Early Q-Sub engagement can reduce timeline overruns by 𝟯𝟬% 𝗶𝗳 𝗻𝗼𝘁 𝗺𝗼𝗿𝗲    2. 𝗗𝗲𝗹𝗮𝘆𝗲𝗱 𝗤𝗠𝗦 𝗜𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 • 𝟮 𝗼𝘂𝘁 𝗼𝗳 𝟯 startups try to build their QMS too late • Retroactive documentation costs atleast 𝟯𝘅 𝗺𝗼𝗿𝗲 • Phased QMS rollout leads to up to 𝟰𝟬%+ 𝗳𝗮𝘀𝘁𝗲𝗿 𝗺𝗮𝗿𝗸𝗲𝘁 𝗲𝗻𝘁𝗿𝘆    3. 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝗚𝗮𝗽𝘀 • 𝗢𝘃𝗲𝗿 𝟱𝟬% of 510(k)s receive AI requests due to weak data • Average delay: 𝟳+ 𝗺𝗼𝗻𝘁𝗵𝘀 • Engaging KOLs early boosts study enrollment by 𝟯𝟬%    4. 𝗥𝗲𝗶𝗺𝗯𝘂𝗿𝘀𝗲𝗺𝗲𝗻𝘁 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝗮𝘀 𝗮𝗻 𝗔𝗳𝘁𝗲𝗿𝘁𝗵𝗼𝘂𝗴𝗵𝘁 • Only 𝟭 𝗶𝗻 𝟰 startups plan reimbursement before FDA submission • Average time from approval to revenue: 𝟭𝟯+ 𝗺𝗼𝗻𝘁𝗵𝘀 • Payer engagement during clinical planning can 𝗰𝘂𝘁 𝘁𝗵𝗮𝘁 𝗶𝗻 𝗵𝗮𝗹𝗳    5. 𝗦𝘂𝗽𝗽𝗹𝘆 𝗖𝗵𝗮𝗶𝗻 𝗩𝘂𝗹𝗻𝗲𝗿𝗮𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 • 𝟴𝟬%+ rely on single-source components • Average shortage delay: 𝟰–𝟱 𝗺𝗼𝗻𝘁𝗵𝘀 • Dual sourcing significantly reduces disruptions    6. 𝗡𝗲𝗴𝗹𝗲𝗰𝘁𝗶𝗻𝗴 𝗣𝗼𝘀𝘁-𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝘂𝗿𝘃𝗲𝗶𝗹𝗹𝗮𝗻𝗰𝗲 • EU MDR has driven PMS costs up • Most startups allocate just 𝟲% of OpEx to PMS • Real-world need: 𝟭𝟮–𝟭𝟱% in the first 2 years post-launch    7. 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝘃𝘀. 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗧𝗶𝗺𝗲𝗹𝗶𝗻𝗲 𝗠𝗶𝘀𝗺𝗮𝘁𝗰𝗵 • Investors expect revenue 𝟭𝟴 𝗺𝗼𝗻𝘁𝗵𝘀 𝗽𝗼𝘀𝘁-𝗦𝗲𝗿𝗶𝗲𝘀 𝗔 • Reality? It takes 𝟯𝟭+ 𝗺𝗼𝗻𝘁𝗵𝘀 on average • Companies that align timelines tend to secure significantly more follow-on funding    𝗧𝗮𝗸𝗲𝗮𝘄𝗮𝘆: MedTech success is about 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗲𝘅𝗲𝗰𝘂𝘁𝗶𝗼𝗻 𝗮𝗰𝗿𝗼𝘀𝘀 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆, 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹, 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗮𝗻𝗱 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗽𝗹𝗮𝗻𝗻𝗶𝗻𝗴. Startups that get these 7 factors right often reduce time-to-market by 𝟯𝟬–𝟰𝟬% and increase their 5-year survival rate to 𝗼𝘃𝗲𝗿 𝟲𝟬% 💬 Want to explore how your startup can beat the odds? Let’s talk, drop me a message to connect

*2025 Q3 HEALTHTECH LATE STAGE FUNDING and M&A RECAP* #RaihanRecaps VC $ in late-stage deals and several notable M&As: 🟣 Series B • Heidi Health | $65M – AI-powered ambient scribe • Assort | $76M – Call center agentic voice AI • Inspiren | $100M – Smart sensors + AI platform powering senior-living and hospital workflow automation • Penguin AI | $30M – Agentic AI full-stack payor automation (prior auth, risk adjustment, payment integrity, claims adjudication) • Optain | $28M – AI-enabled tele-ophthalmology detecting retinal disease remotely • Daymark Health | $20M – AI-driven cancer-care coordination and navigation. • Teton.ai | $20M – Computer-vision platform supporting nurses in long-term care and hospitals 🟢 Series C • Ambience | $242M | Ambient AI platform for documentation, coding, and clinical documentation integrity (CDI) • Midi Health | $50M | $150M ARR – Virtual care for women’s midlife health • Diana Health | $55M – Tech-enabled Women’s-health clinics • XO Health | $52M – VBC commercial insurance network • Nava Benefits | $30M – Tech-enabled benefits brokerage simplifying plan design for employers • Sensi.AI | $45M – Audio-based AI monitoring and analytics for senior care 🔵 Later-Stage / Growth / Series D–E • Strive Health | $550M (Series D) – VBC kidney-care managing CKD and ESRD populations • Thyme Care | $97M (Series D) – Oncology-navigation company coordinating cancer care across payors & providers • Harbor Health | $130M (Growth) – Tech-enabled payvidor (urgent care, health plan, ACO) • DUOS | $130M (Growth) – AI-powered benefits-engagement platform for older adults and caregivers • Twin Health | $53M (Series E) – AI-driven metabolic-health platform using digital twins to reverse diabetes • EliseAI | $250M (Series E) – Conversational AI automation for real estate and healthcare • Judi Health fka CapitalRx | $400M (Series F) | AI-Powered Health Benefits Platform ⚫ M & A • Talkspace → acquires Wisdo – Adds peer-support and loneliness-reduction to its mental-health platform. • R1 RCM → acquires Phare Health – Adds AI-native coding & documentation tools to its RCM suite. • Innovaccer → acquires Story Health – Deepens specialty-care and cardiology enablement. • RevSpring → Kyruus Health - Combines provider search, scheduling, payment solutions My take: 1️⃣ AI agentification is going vertical - from payor ops (Penguin, Assort) to clinical workflows (Heidi, Ambience), we’re seeing deep domain-specific agent stacks replace human tasks end-to-end. 2️⃣ Late-stage capital is chasing operating leverage - $100M+ rounds (Strive, EliseAI, Judi Health) are fueling models that fuse software + services, not pure SaaS, signaling investors want margin-expanding automation. 3️⃣ M&A momentum signals consolidation of AI infrastructure — Incumbents buying workflow intelligence rather than building it.

The global HealthTech funding map may just be rebalacing. Here's where capital is flowing in 2026. 🇬🇧 𝗨𝗞: £𝟯𝟬𝗠 𝗛𝗲𝗮𝗹𝘁𝗵𝗧𝗲𝗰𝗵 𝗔𝗱𝗼𝗽𝘁𝗶𝗼𝗻 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗙𝘂𝗻𝗱 The NHS didn't release £30M for more pilots. They released it for adoption infrastructure. The difference matters. The UK has innovation fatigue. What NHS needs now is implementation confidence. The companies winning this capital understand that "innovative technology" doesn't unlock procurement anymore. Demonstrable adoption pathways do. If your pitch deck still leads with features, you're solving 2023's problem. 🇪🇺 𝗘𝘂𝗿𝗼𝗽𝗲: €𝟭𝟰𝗕 𝗛𝗼𝗿𝗶𝘇𝗼𝗻 𝗘𝘂𝗿𝗼𝗽𝗲 𝟮𝟬𝟮𝟲-𝟮𝟬𝟮𝟳 Europe just approved €14 billion for Horizon Europe's 2026-2027 work programme. Health, digital, and AI infrastructure are prioritised. Calls opening throughout Q1. This isn't academic R&D. This is infrastructure capital for companies building cross-border data systems, AI diagnostics, and interoperable health platforms. Europe is betting on systems, not apps. Single-market solutions won't capture this. Multi-country architecture will. 🌍 𝗔𝗳𝗿𝗶𝗰𝗮: $𝟰.𝟭𝗕 𝗧𝗼𝘁𝗮𝗹 𝗙𝘂𝗻𝗱𝗶𝗻𝗴 (+𝟮𝟱% 𝗬𝗼𝗬), 𝗛𝗲𝗮𝗹𝘁𝗵𝗧𝗲𝗰𝗵 +𝟮𝟯𝟮% African tech funding hit $4.1 billion in 2025, up 25% year-over-year. HealthTech specifically? $215M. Up 232%. This marks the first time since 2021-2022 that non-fintech sectors exceeded $200M in annual equity funding. The ecosystem isn't emerging anymore. It's executing. Where it's concentrating: → Kenya: $1.04B raised (+72% YoY) → Kenya, South Africa, Egypt, Nigeria: 72% of total capital The 'Africa is too early for HealthTech' narrative just died. Thank you to Rowena Luk from Africa Health Ventures for the data. What the three signals tell us: • UK is funding adoption infrastructure. • Europe is funding cross-border systems. • Africa is funding B2B backbone. • The global theme? Capital is flowing to implementation, not innovation theater. If you're post-Series A and your funding strategy still assumes investors reward potential over proof, you're pricing for the wrong market cycle. ----- ⭐I’m Sara - a HealthTech strategic advisor, fractional operator, and 4x founder who’s scaled ventures to £10M+ ARR across the UK, Europe and Africa. I help founders navigate complexity, rebuild strategic clarity, and scale sustainably. Founder of Well Purposed.

Healthcare Cannot Move at Silicon Valley Speed. Silicon Valley rewards speed. Healthcare punishes mistakes. That’s the tension nobody wants to talk about. AI models are iterating weekly. Hospitals update protocols yearly. Regulatory bodies take months sometimes years. And that’s not incompetence. It’s intentional. Because in tech, a 2% error rate is a bug. In medicine, it’s harm. Here’s why healthcare can’t adopt AI at startup velocity: • Clinical systems carry liability When software fails in healthcare, physicians and institutions answer for it. • Edge cases aren’t rare they’re routine Patients rarely fit clean training data patterns. • Trust takes longer than deployment You can roll out a tool in 30 days. Trust takes years. • Outcomes lag implementation True validation requires long-term follow-up not just performance metrics. I’m not arguing for slow innovation. I’m arguing for aligned innovation. Speed without safeguards creates backlash. And backlash kills progress faster than caution ever will. If we want AI to truly transform healthcare… We have to respect the pace of responsibility. Tech leaders what would responsible speed look like in clinical AI? #HealthcareAI #DigitalTransformation #AIethics #HealthLeadership #DrGPT

Move fast and break things vs. moving at the speed of trust Which should health-tech adopt? I've lived both sides of this. I left community healthcare in part because I kept hitting walls. People unwilling to question "the way we've always done it," even when those ways were grinding people down and delaying care that couldn't wait. Real problems were going unsolved while bureaucracy protected itself. So I get the urgency. We're solving life-and-death issues. Slow has a cost. But I've also watched tech teams sprint so hard they "break things," and in healthcare, "things" means people. Providers. Patients. The communities we say we're serving. Here's what tech keeps getting wrong: they skip the trust part. They build for people instead of with them. They launch fast, ask questions later, and wonder why adoption tanks or why communities reject what looked good on paper. Trust isn't just a nice-to-have. It's infrastructure. And when you skip it, your product fails, or worse, it does harm. adrienne maree brown teaches us to move at the speed of trust. What I've learned is that when you invest in trust early, when you co-design with the folks most impacted and compensate their expertise and build real accountability before launch, you actually move faster later. You avoid the blowback. You get better outcomes. People actually use what you build. Moving fast without safeguards causes harm. I've seen it happen. So if you're building in health-tech: - Who did you actually build with, and did you pay them? - What's stopping harm before launch, not after? - When things go wrong, who's accountable? - Are you measuring trust or just counting users (also hate this word)? What would you add? #DigitalHealth #HealthTech #HealthCareOnLinkedIn Image credit in comments